Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icenticaftor in COPD
NCT02449018Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Icenticaftor in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Apr 2015; status: completed.
02
Drugs
Icenticaftor
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02449018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449018.